Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
European Journal of Pharmacology
|
December 7, 2021
Research progress on the potential novel analgesic BU08028
Ya Wang, Di Qin, Zhihua Guo, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
May 1, 2023
The Effect of Endovascular Treatment of Renal Artery Stenoses on Coexistent Aneurysms Associated with Fibromuscular Dysplasia
Yang Chen, Hui Dong, Yubao Zou, et al.
Antioxidants (Basel, Switzerland)
|
February 26, 2025
Pharmacological Mechanism and Drug Research Prospects of Ginsenoside Rb1 as an Antidepressant
Shuhui Zhuang, Fuqiang Shi, Nazzareno Cannella, et al.
Molecular Medicine Reports
|
June 20, 2012
βig-h3 supports gastric cancer cell adhesion, migration and proliferation in peritoneal carcinomatosis
Zhen Li, Zhifeng Miao, Guanghua Jin, et al.
International Journal of Surgery (London, England)
|
May 13, 2025
Antecubital versus femoral approach for adrenal venous sampling in the patients with primary aldosteronism: a randomized controlled trial
Hui Dong, Hongwu Li, Yujie Zuo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
March 4, 2024
Clinical features, laboratory findings and treatment of juxtaglomerular cell tumors: a systemic review
Hui Dong, Yujie Zuo, Xuanqi An, et al.
Journal of Endocrinological Investigation
|
March 15, 2025
Comparison of three approaches for adrenal venous sampling in patients with primary aldosteronism
Hui Dong, Yujie Zuo, Hongwu Li, et al.
Medicine
|
November 27, 2025
Prediction of 180-day post-admission's GOS in patients with spontaneous intracerebral hemorrhage based on explainable machine learning technology
Cuijie Yuan, Mengyao Wang, Yafang Jiang, et al.
Neuropharmacology
|
June 20, 2024
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
Nazzareno Cannella, Veronica Lunerti, Qianwei Shen, et al.
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
Veronica Lunerti, Qianwei Shen, Hongwu Li, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
European Journal of Pharmacology
|
December 7, 2021
Research progress on the potential novel analgesic BU08028
Ya Wang, Di Qin, Zhihua Guo, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
May 1, 2023
The Effect of Endovascular Treatment of Renal Artery Stenoses on Coexistent Aneurysms Associated with Fibromuscular Dysplasia
Yang Chen, Hui Dong, Yubao Zou, et al.
Antioxidants (Basel, Switzerland)
|
February 26, 2025
Pharmacological Mechanism and Drug Research Prospects of Ginsenoside Rb1 as an Antidepressant
Shuhui Zhuang, Fuqiang Shi, Nazzareno Cannella, et al.
Molecular Medicine Reports
|
June 20, 2012
βig-h3 supports gastric cancer cell adhesion, migration and proliferation in peritoneal carcinomatosis
Zhen Li, Zhifeng Miao, Guanghua Jin, et al.
International Journal of Surgery (London, England)
|
May 13, 2025
Antecubital versus femoral approach for adrenal venous sampling in the patients with primary aldosteronism: a randomized controlled trial
Hui Dong, Hongwu Li, Yujie Zuo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
March 4, 2024
Clinical features, laboratory findings and treatment of juxtaglomerular cell tumors: a systemic review
Hui Dong, Yujie Zuo, Xuanqi An, et al.
Journal of Endocrinological Investigation
|
March 15, 2025
Comparison of three approaches for adrenal venous sampling in patients with primary aldosteronism
Hui Dong, Yujie Zuo, Hongwu Li, et al.
Medicine
|
November 27, 2025
Prediction of 180-day post-admission's GOS in patients with spontaneous intracerebral hemorrhage based on explainable machine learning technology
Cuijie Yuan, Mengyao Wang, Yafang Jiang, et al.
Neuropharmacology
|
June 20, 2024
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
Nazzareno Cannella, Veronica Lunerti, Qianwei Shen, et al.
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
Veronica Lunerti, Qianwei Shen, Hongwu Li, et al.
Page
of 5